We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Assessing the Burden of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers in Mexico City: A Data-Driven Call to Action.
- Authors
Antonio-Villa, Neftali Eduardo; Bello-Chavolla, Omar Yaxmehen; Vargas-Vázquez, Arsenio; Fermín-Martínez, Carlos A; Márquez-Salinas, Alejandro; Pisanty-Alatorre, Julio; Bahena-López, Jessica Paola
- Abstract
Background Healthcare workers (HCWs) could be at increased occupational risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections due to increased exposure. Information regarding the burden of coronavirus disease 2019 (COVID-19) epidemic in HCWs living in Mexico is scarce. Here, we aimed to explore the epidemiology, symptoms, and risk factors associated with adverse outcomes in HCWs in Mexico City. Methods We explored data collected by the National Epidemiological Surveillance System in Mexico City, in HCWs who underwent real-time reverse transcription polymerase chain reaction (RT-PCR) test. We explored COVID-19 outcomes in HCWs and the performance of symptoms to detect SARS-CoV-2 infection. Results As of 20 September 2020, 57 758 HCWs were tested for SARS-CoV-2 and 17 531 were confirmed (30.35%); 6610 were nurses (37.70%), 4910 physicians (28.0%), 267 dentists (1.52%), and 5744 laboratory personnel and other HCWs (32.76%). Overall, 2378 HCWs required hospitalization (4.12%), 2648 developed severe COVID-19 (4.58%), and 336 required mechanical-ventilatory support (.58%). Lethality was recorded in 472 (.82%) cases. We identified 635 asymptomatic SARS-CoV-2 infections (3.62%). Compared with general population, HCWs had higher incidence, testing, asymptomatic cases, and mortality rates. No individual symptom offers adequate performance to detect SARS-CoV2. Older HCWs with chronic noncommunicable diseases and severe respiratory symptoms were associated with higher risk for adverse outcome; physicians were at higher risk compared with nurses and other HCWs. Conclusions We report a high prevalence of SARS-CoV-2 infection in HCWs in Mexico City. Symptoms as a screening method are not efficient to discern those HCWs with a positive PCR-RT test. Particular attention should focus on HCWs with risk factors to prevent adverse outcomes.
- Subjects
MEXICO; REVERSE transcriptase polymerase chain reaction; COVID-19; MEDICAL personnel; DISEASE incidence; OCCUPATIONAL exposure; SEVERITY of illness index; ARTIFICIAL respiration; PSYCHOSOCIAL factors; HOSPITAL care; DESCRIPTIVE statistics; ECONOMIC aspects of diseases; POLYMERASE chain reaction; COVID-19 testing
- Publication
Clinical Infectious Diseases, 2021, Vol 73, Issue 1, pe191
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciaa1487